Kimberly Kenton to Cost-Benefit Analysis
This is a "connection" page, showing publications Kimberly Kenton has written about Cost-Benefit Analysis.
Connection Strength
0.194
-
Cost-effectiveness Analysis of Universal Cystoscopy at the Time of Benign Laparoscopic Hysterectomy. J Minim Invasive Gynecol. 2021 08; 28(8):1470-1483.
Score: 0.153
-
The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial. Contemp Clin Trials. 2014 Mar; 37(2):272-83.
Score: 0.024
-
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods. Clin Trials. 2009 Apr; 6(2):162-71.
Score: 0.017